Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The use of a low starch diet in the treatment of patients suffering from ankylosing spondylitis.

Ebringer A, Wilson C.

Clin Rheumatol. 1996 Jan;15 Suppl 1:62-66. Review.

PMID:
8835506
2.

The link between ankylosing spondylitis, Crohn's disease, Klebsiella, and starch consumption.

Rashid T, Wilson C, Ebringer A.

Clin Dev Immunol. 2013;2013:872632. doi: 10.1155/2013/872632. Epub 2013 May 27. Review.

3.

Raised incidence of ankylosing spondylitis among Inuit populations could be due to high HLA-B27 association and starch consumption.

Rashid T, Wilson C, Ebringer A.

Rheumatol Int. 2015 Jun;35(6):945-51. doi: 10.1007/s00296-014-3164-2. Epub 2014 Nov 11. Review.

PMID:
25385438
4.

IgA antibodies against Klebsiella and other Gram-negative bacteria in ankylosing spondylitis and acute anterior uveitis.

Sprenkels SH, Van Kregten E, Feltkamp TE.

Clin Rheumatol. 1996 Jan;15 Suppl 1:48-51.

PMID:
8835503
6.

Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.

Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S, Ebringer A.

J Rheumatol. 1997 Jan;24(1):109-14.

PMID:
9002020
7.

Role of Klebsiella and collagens in Crohn's disease: a new prospect in the use of low-starch diet.

Rashid T, Ebringer A, Tiwana H, Fielder M.

Eur J Gastroenterol Hepatol. 2009 Aug;21(8):843-9. doi: 10.1097/MEG.0b013e328318ecde. Review.

PMID:
19352192
8.

B27 disease is a new autoimmune disease that affects millions of people.

Ebringer A, Rashid T.

Ann N Y Acad Sci. 2007 Sep;1110:112-20.

PMID:
17911426
10.

Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis.

Tiwana H, Wilson C, Walmsley RS, Wakefield AJ, Smith MS, Cox NL, Hudson MJ, Ebringer A.

Rheumatol Int. 1997;17(1):11-6.

PMID:
9194209
12.

IgA antibodies in HLA-B27 associated acute anterior uveitis and ankylosing spondylitis.

Sprenkels SH, Uksila J, Vainionpää R, Toivanen P, Feltkamp TE.

Clin Rheumatol. 1996 Jan;15 Suppl 1:52-6.

PMID:
8835504
13.
14.
15.

Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.

Sahly H, Kekow J, Podschun R, Schaff M, Gross WL, Ullmann U.

Infect Immun. 1994 Nov;62(11):4838-43.

16.

Molecular mimicry: the geographical distribution of immune responses to Klebsiella in ankylosing spondylitis and its relevance to therapy.

Ebringer A, Ahmadi K, Fielder M, Rashid T, Tiwana H, Wilson C, Collado A, Tani Y.

Clin Rheumatol. 1996 Jan;15 Suppl 1:57-61. Review.

PMID:
8835505
17.

Persistence of HLA-B27 cross-reactive bacteria in bowel flora of patients with ankylosing spondylitis.

Prendergast JK, McGuigan LE, Geczy AF, Kwong TS, Edmonds JP.

Infect Immun. 1984 Dec;46(3):686-9.

18.

Spondyloarthritis, uveitis, HLA-B27 and Klebsiella.

Ebringer A, Baines M, Ptaszynska T.

Immunol Rev. 1985 Aug;86:101-16.

PMID:
2412951
19.

A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections.

Ebringer A, Rashid T, Tiwana H, Wilson C.

Clin Rheumatol. 2007 Mar;26(3):289-97. Epub 2006 Aug 29. Review.

PMID:
16941202
20.

IgG and IgA immune response against klebsiella in HLA-B27-associated anterior uveitis.

Kijlstra A, Luyendijk L, van der Gaag R, van Kregten E, Linssen A, Willers JM.

Br J Ophthalmol. 1986 Feb;70(2):85-8.

Supplemental Content

Support Center